It has been evaluated that nearly 12% of European patients experiencing PD, and 15 to 20% of Ashkenazi Jewish patients experiencing PD, are robustly linked with mutations and variations in the GBA gene, creating GBA as a critical genetic hazard for PD [102]. This evidence concerns the gene GBA1 and Parkinson disease.